|
|
|
|
Santhera's FJORD Phase IIb Study Demonstrates Efficacy of JP-1730/Fipamezole for the Treatment of Dyskinesia i
- Santhera Pharmaceuticals (SIX: SANN), a Swiss specialty pharmaceutical company focused on neuromuscular diseases, announced today positive data from its Phase IIb study (FJORD).The key finding of the trial is that JP-1730/ fipamezole...
|
|
|
Clinical Data Presented at International Congress Showed Treatment With Neupro(R) (rotigotine) Significantly I
- Data Presented at the 13th International Congress of Parkinson's Disease and Movement Disorders - Long-term Treatment With rotigotine was Generally Well Tolerated in Patients With Early Stage Parkinson's...
|
|
|
Zonisamide Safe and Effective in Long-Term Treatment of Parkinson's Disease: Presented at MDS
my personal edition> parkinson's > news E-Mail this DGDispatch to a colleague DGDispatch PARIS -- June 12, 2009 -- Long-term treatment with zonisamide is safe and effective in controlling the symptoms of Parkinson's disease (PD...
|
|
|
Patients Treated With Preladenant for Parkinson's Disease Experience Reduced 'Off' Time and Increased 'On' Tim
my personal edition> parkinson's > news E-Mail this DGDispatch to a colleague DGDispatch PARIS -- June 12, 2009 -- Preladenant controls symptoms associated with 'wearing off' in patients with moderate to severe Parkinson's...
|
|
|
Zonisamide Safe and Effective in Long-Term Treatment of Parkinson's Disease: Presented at MDS
-- Long-term treatment with zonisamide is safe and effective in controlling the symptoms of Parkinson's disease (PD) in patients, without those patients developing disabling dyskinesia, researchers reported here at the Movement...
|
|
|
Tardive dyskinesia associated with aripiprazole;
_ Tardive dyskinesia associated with aripiprazole;.
|
|
|
Resting Tremor Among Several Factors Associated With the Development, Severity of Levodopa-Induced Dyskinesia:
-- The development and severity of levodopa (L-dopa)-induced dyskinesia (LID) in patients with Parkinson's disease (PD) is associated not only by treatment with L-dopa but also with several factors of the patient's PD progression,...
|
|
|
Use of aripiprazole in tardive dyskinesia: An open label study of six cases
(Click the title below to leave the MDLinx Network and go to the Journal's Website) World Journal of Biological Psychiatry, 06/10/09 Print Save in My Library Free Abstract Rajarethinam R et al.- The study supports our hypothesis that...
|
|
|
Why are some Parkinson's disease patients unaware of their dyskinesias?
Study of whether anosognosia for dyskinesias in PD results from a failure to detect discrepancies between intended and actual movement Investigation of the ability to detect a discrepancy between intended movement and...
|
|
|
FDA panel to vote on antipsychotic drugs for kids
ADELPHI, Md.- A Food and Drug Administration advisory committee will vote Wednesday on whether the makers of three blockbuster antipsychotic drugs already widely prescribed 'off-label' to children and teens should be allowed to market...
|
|
|
Bipolar Disorder and Dopamine Dysfunction: An Indirect Approach Focusing on Tardive Movement Syndromes in a Na
_ Bipolar Disorder and Dopamine Dysfunction: An Indirect Approach Focusing on Tardive Movement Syndromes in a Na.
|
|
|
Bipolar Disorder and Dopamine Dysfunction: An Indirect Approach Focusing on Tardive Movement Syndromes in a Na
_ Bipolar Disorder and Dopamine Dysfunction: An Indirect Approach Focusing on Tardive Movement Syndromes in a Na.
|
|
|
Effects of selective serotonin reuptake inhibitors on motor neuron survival
Anderson LB et al.- Recently tardive dyskinesia, as well as other movement disorders, have been found to be a clinical side effect of SSRIs. Motor neurons were challenged with fluoxetine and paroxetine at clinically relevant...
|
|
|
Biovail to acquire tetrabenazine rights from Cambridge Labs
Biovail Corporation's wholly-owned subsidiary has entered into a definitive agreement to acquire worldwide development and commercialization rights to the entire portfolio of tetrabenazine products, including Xenazine/Nitoman (tetrabenazine...
|
|
|
Biovail Announces Acquisition of Worldwide Rights to Tetrabenazine
TORONTO--(BUSINESS WIRE)--Biovail Corporation (NYSE:BVF - News) (TSX:BVF - News) today announced a wholly owned subsidiary has entered into a definitive agreement to acquire worldwide development and commercialization rights to the entire...
|
|
|
UPDATE 1-US panel partly backs wider use of AstraZeneca drug
(Adds panel member quote, background) SILVER SPRING, Md., April 8 (Reuters) - AstraZeneca Plc's (AZN.L The committee of Food and Drug Administration advisers said the drug appeared safe when added to other medicines to fight depression.
|
